Mumbai: Avio Smart Market Stack Limited (ASMS) announced on Wednesday, 30 September 2026, a collaboration with Huwel Lifesciences to expand access to molecular diagnostics across India’s private healthcare sector.
Commercialisation Platform
The partnership will focus on building a nationwide commercialisation platform for Cubo, Huwel’s ultra-compact RT-PCR system. This initiative aims to reach hospitals, diagnostic centres, research institutions, and smaller healthcare facilities.
Sales and Distribution
ASMS and Huwel Lifesciences plan to establish a dedicated sales and distribution infrastructure. This includes recruiting senior sales leadership, forming specialised sales teams, and developing channel partnerships.
Managing Director Comments
N Vidhya Sagar Reddy, Managing Director, ASMS, said the next phase focuses on building the commercial infrastructure for advanced molecular diagnostic technologies. Reddy noted that Cubo's compact format allows RT-PCR capabilities to reach hospitals and laboratories beyond traditional centralised systems.
Market Focus
The commercialisation strategy will target private hospitals, diagnostic chains, independent laboratories, and medical colleges. The sales organisation will use direct sales and channel partnerships, supported by product demonstrations and installation support.
Ecosystem Development
Beyond instrument deployment, the companies intend to develop an ecosystem around the Cubo platform. This will include compatible molecular assays and consumables to support recurring testing requirements.
Disclaimer: This story is based on company exchange filings and is for informational purposes only. Investors should evaluate risks before making decisions.
